TuHURA Biosciences, Inc./NV — Form 8-K/A
Filed September 17, 2026 · analyzed by the 8-K Agent
8-K/A
— Neutral
significance 28/100
What the filing says
TuHURA Biosciences adopted a new 2026 Inducement Equity Incentive Plan on September 10, 2026, reserving 5,000,000 shares for issuance as employment inducement awards under Nasdaq Rule 5635(c)(4). The plan permits grants of options, restricted stock, RSUs, and other equity awards exclusively to new employees or those returning after a bona fide period of non-employment, without stockholder approval. The included stock option agreement provides for one-third vesting annually over three years, with 90-day post-termination exercise windows for non-Cause terminations.
Why this rating
5M shares represents ~4.5% of typical biotech float; standard inducement plan mechanism for hiring. Boilerplate equity authorization with no specific grants disclosed yet—routine governance action.
See more from September 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.